ID   YCU-L891
AC   CVCL_8018
SY   YCU L891
DR   Cosmic; 1136977
DR   Cosmic; 1556187
DR   Wikidata; Q54995350
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
CC   Population: Japanese.
CC   Doubling time: 16.58 hours (PubMed=21362583).
CC   HLA typing: A*24:02 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Misspelling: KCC L891; PubMed=21362583.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 8
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 9,15
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8023 ! YCU-T891
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
RX   PubMed=26780976; DOI=10.3892/or.2016.4573;
RA   Sano, Daisuke
RA   Matsuda, Hideki
RA   Ishiguro, Yukari
RA   Nishimura, Goshi
RA   Kawakami, Mariko
RA   Tsukuda, Mamoru
RT   "Corrigendum: Antitumor effects of IDN5109 on head and neck squamous
RT   cell carcinoma.";
RL   Oncol. Rep. 35:2494-2494(2016).
//
RX   PubMed=18097577; DOI=10.3892/or.19.1.65;
RA   Taguchi, Takahide
RA   Tsukuda, Mamoru
RA   Imagawa-Ishiguro, Yukari
RA   Kato, Yasumasa
RA   Sano, Daisuke
RT   "Involvement of EGFR in the response of squamous cell carcinoma of the
RT   head and neck cell lines to gefitinib.";
RL   Oncol. Rep. 19:65-71(2008).
//
RX   PubMed=21362583; DOI=10.1016/j.anl.2011.01.018;
RA   Sakakibara, Atsuko
RA   Tsukuda, Mamoru
RA   Kondo, Norio
RA   Ishiguro, Yukari
RA   Kimura, Machiko
RA   Fujita, Kyoko
RA   Takahashi, Hideaki
RA   Matsuda, Hideki
RT   "Examination of the optimal condition on the in vitro sensitivity to
RT   telomelysin in head and neck cancer cell lines.";
RL   Auris Nasus Larynx 38:589-599(2011).
//
RX   PubMed=26781072; DOI=10.3892/or.2016.4574;
RA   Sano, Daisuke
RA   Kawakami, Mariko
RA   Fujita, Kyoko
RA   Kimura, Machiko
RA   Yamashita, Yukiko
RA   Ishiguro, Yukari
RA   Nishimura, Goshi
RA   Matsuda, Hideki
RA   Tsukuda, Mamoru
RT   "Corrigendum: Antitumor effects of ZD6474 on head and neck squamous
RT   cell carcinoma.";
RL   Oncol. Rep. 35:2495-2495(2016).
//
RX   PubMed=21631644; DOI=10.1111/j.1349-7006.2011.01999.x;
RA   Kondo, Norio
RA   Tsukuda, Mamoru
RA   Taguchi, Takahide
RA   Nakazaki, Kouichi
RA   Sakakibara, Atsuko
RA   Takahashi, Hideaki
RA   Toth, Gabor
RA   Nishimura, Goshi
RT   "Gene status of head and neck squamous cell carcinoma cell lines and
RT   cetuximab-mediated biological activities.";
RL   Cancer Sci. 102:1717-1723(2011).
//